Roche Virtual Event – Update following ASH 2022
Roche has hosted a virtual event on Wednesday, 14 December 2022.
| Agenda | |
|---|---|
| Welcome | Bruno Eschli, Head of Investor Relations |
| Hematology franchise overview | Peter Ahnesorg, Franchise Head Hematology |
| Review of key clinical data presented at ASH | Charles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development |
| Spark Therapeutics, Inc. (SPK-8011) clinical data update | Gallia G. Levy, MD, PhD, Chief Medical and Product Strategy Officer |
Webinar Replay
Investors